News

Jim Cramer on Biohaven Ltd. (BHVN): “I Think That This is a Buy”
We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at ...
Morgan Stanley Keeps Their Buy Rating on Biohaven Ltd. (BHVN)
Morgan Stanley analyst Terence Flynn reiterated a Buy rating on Biohaven Ltd. (BHVN – Research Report) today and set a price target of $63.00. The company’s shares opened toda ...
Biohaven Ltd. (BHVN) Receives a Buy from TD Cowen
In a report released today, Tyler Van Buren from TD Cowen maintained a Buy rating on Biohaven Ltd. (BHVN – Research Report), with a price target of $75.00. The company’s share ...
Biohaven Ltd. (BHVN)’s BHV-1400 Cuts Disease Antibody by 81% in IgA Nephropathy
Biohaven Ltd. (NYSE:BHVN) has announced major breakthroughs with its novel precision immunology therapies, BHV-1400 and ...
Biohaven says anti-cancer agent cut tumor size with Regeneron’s Libtayo in Phase 1 trial
Biohaven (NYSE:BHVN) stock gains on tumor-shrinking results for the company's cancer drug BHV-1510 with Regeneron's (REGN) ...